American Ebola patients released

Both Americans who were treated for the Ebola virus have been
discharged from the hospital.

"Today is a miraculous day," Dr. Kent Brantlysaid at a news conference
in Atlanta with staff of Emory University Hospital. "I am thrilled to
be alive, to be well and to be reunited with my family." The hospital
announced he was being discharged Thursday.

The other patient, Nancy Writebol, was released Tuesday, and is
choosing not to make public comments, the hospital said.

"We are tremendously pleased with Dr. Brantly and Mrs. Writebol's
recovery," said Dr. Bruce Ribner, director of Emory's Infectious
Disease Unit.

"What we learned in caring for them will help advance the world's
understanding of how to treat Ebola infections and help, hopefully, to
improve survival" in other parts of the world, Ribner said at a news
conference.

Both patients were evacuated from Liberia earlier this month in a
plane specially equipped with an isolation tent and accompanied by
medical staff outfitted in head-to-foot protective clothing.

The plane was able to take only one patient at a time and made two
trips. They were taken to an isolation unit at Emory.
Joy and relief

Brantly was in Liberia for faith-based charity Samaritan's Purse, and
its president, Franklin Graham expressed joy over the doctor's
release.

"Today I join all of our Samaritan's Purse team around the world in
giving thanks to God as we celebrate Dr. Kent Brantly's recovery from
Ebola," he said.

Writebol's husband David, who was with her in Africa, visited her at
Emory on Sunday, he said in a statement. She is recovering, he said.

He stood outside the isolation room, as they looked at each other
through the glass.

"We both placed our hands on opposite sides of the glass, moved with
tears to look at each other again," he said.

Experimental medication
For Brantly to leave isolation, two blood tests done in a two-day
period had to come back negative.

The Ebola virus spreads via direct contact with bodily fluids, like
blood, sweat and feces. Brantly's will no longer be infectious.

There is a slight possibility that the virus could linger for up to
three months in his semen, according to the World Health
Organization.

The virus has no known cure, and left untreated, infections can be
deadly in up to 90% of cases. Nearly half the patients receiving
medical care in the current outbreak in Liberia, Sierra Leone, Nigeria
and Guinea are surviving.

Treatment consists of giving fluids, monitoring vital signs and
responding to acute medical crises. Symptoms include fever, aches,
diarrhea and bleeding.

Brantly and Writebol also received an experimental drug called ZMapp,
which was also given to three healthcare workers in Liberia, who
appear to be recovering.

Brantly and Writebol were the first known people infected with Ebola
to enter the United States.

Their arrival triggered a surge of angst on social media from people
afraid the patients could spread the virus.

But experts have said that additional infected people could cross U.S.
borders by happenstance, given the proliferation of international air
travel and the enormity of the current outbreak.

But they have dismissed the notion that infection could spread
significantly in the country, thus turning into an outbreak.

Record outbreak

More than 1,350 people have died in the West African Ebola outbreak
since the first cases drew attention in March, the WHO said on
Wednesday.

Aid workers are fighting an uphill battle to stop the disease, as it
continues to spread. Financial and human resources have been
stretched.

An emergency research "all call" was issued Thursday by medical
charity Wellcome Trust and United Kingdom's Department for
International Development to find a drug to stop the outbreak.

They are making $10.8 million available to fund research. Wellcome
Trust is committing another $66.5 million to the development of health
research scientists in Africa, who are studying many deadly diseases
there.

Canada's public health agency had 800 to 1,000 doses of a vaccine
known as VSV-EBOV delivered to health officials in Liberia last week.

Mapp Biopharmaceuticals, which produces ZMapp, said it has sent its
entire stock of the experimental drug overseas to fight the outbreak.